» Articles » PMID: 34402226

Patient Perspectives and Preferences Regarding Gout and Gout Management: Impact on Adherence

Abstract

Background: Patient-centered management is becoming increasingly important in gout, but there are limited studies exploring patients' perspectives and preferences. We aimed to investigate patients' perspectives and preferences regarding gout and gout management, and their impacts on adherence to urate lowering therapy (ULT).

Methods: A paper-based survey was performed in patients with gout seen at the rheumatology outpatient clinics of 16 tertiary hospitals. The survey included questions regarding demographics, comorbidities, gout attacks, current treatment and adherence, and patients' perspectives and preferences regarding gout and gout management. Multivariate regression analysis was performed to determine the factors associated with ULT adherence.

Results: Of 809 surveyed patients with gout, 755 (94.5%) were using ULT. Among those using ULT, 89.1% had ≥ 80% adherence to ULT. Majority of the patients knew management strategies to some extent (94.8%), perceived gout as a life-long disease (91.2%), and were making efforts toward practicing at least one lifestyle modification (89.2%). Most patients (71.9%) obtained information about gout management during their clinic visits. Approximately half of the patients (53.6%) preferred managing their disease with both ULT and lifestyle modification, 28.4% preferred ULT only, and 17.4% preferred lifestyle modification only. Adherence was better in patients with older age (odds ratio [OR], 1.03), those with better knowledge of gout management strategies (OR, 3.56), and those who had preference for ULT (OR, 2.07).

Conclusion: Patients' perspectives and management preferences had high impacts on adherence to ULT in gout. Consideration of patients' perspectives and preferences is important for achieving the desired clinical outcome in gout.

Citing Articles

Self-management behavior preferences and influencing factors in Chinese patients with recurrent gout: A qualitative study.

Hao X, Wang A, Huang H, Sun Y, Duan Y, Sun S Int J Nurs Sci. 2024; 11(5):544-552.

PMID: 39698134 PMC: 11650676. DOI: 10.1016/j.ijnss.2024.10.001.


Support needs of gout patients and suitability of eHealth to address these needs.

van der Ven J, van den Bemt B, Ariaans F, Vriezekolk J, Flendrie M, Verhoef L Rheumatol Adv Pract. 2024; 8(4):rkae125.

PMID: 39439748 PMC: 11494372. DOI: 10.1093/rap/rkae125.


Patient and provider medication preferences affect treatment outcomes among adolescents and young adults with opioid use disorder.

Monico L, Fletcher J, Ross T, Schwartz R, Fishman M, Gryczynski J J Subst Use Addict Treat. 2024; 162:209334.

PMID: 38531508 PMC: 11163270. DOI: 10.1016/j.josat.2024.209334.


Patient Preferences and Their Influence on Chronic Hepatitis B-A Review.

Zhang L, Liu Y, Tian J Patient Prefer Adherence. 2023; 17:3119-3124.

PMID: 38053533 PMC: 10695120. DOI: 10.2147/PPA.S433283.


Reliability and Validity of the Korean Version of the Gout Impact Scale.

Kim M, Kim J, Lee J, Moon K, Shin K J Korean Med Sci. 2023; 38(35):e266.

PMID: 37667577 PMC: 10477077. DOI: 10.3346/jkms.2023.38.e266.


References
1.
Dalbeth N, Petrie K, House M, Chong J, Leung W, Chegudi R . Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability. Arthritis Care Res (Hoboken). 2011; 63(11):1605-12. DOI: 10.1002/acr.20570. View

2.
Joo K, Kwon S, Lim M, Jung K, Joo H, Park W . Prevention of comorbidity and acute attack of gout by uric acid lowering therapy. J Korean Med Sci. 2014; 29(5):657-61. PMC: 4024939. DOI: 10.3346/jkms.2014.29.5.657. View

3.
FitzGerald J, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles A . 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res (Hoboken). 2020; 72(6):744-760. PMC: 10563586. DOI: 10.1002/acr.24180. View

4.
Kiltz U, Smolen J, Bardin T, Cohen Solal A, Dalbeth N, Doherty M . Treat-to-target (T2T) recommendations for gout. Ann Rheum Dis. 2016; 76(4):632-638. DOI: 10.1136/annrheumdis-2016-209467. View

5.
Yin R, Li L, Zhang G, Cui Y, Zhang L, Zhang Q . Rate of adherence to urate-lowering therapy among patients with gout: a systematic review and meta-analysis. BMJ Open. 2018; 8(4):e017542. PMC: 5898304. DOI: 10.1136/bmjopen-2017-017542. View